Argyle Capital Partners, LLC Pfizer Inc Transaction History
Argyle Capital Partners, LLC
- $139 Billion
- Q3 2025
A detailed history of Argyle Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Argyle Capital Partners, LLC holds 12,643 shares of PFE stock, worth $317,086. This represents 0.23% of its overall portfolio holdings.
Number of Shares
12,643
Previous 13,973
9.52%
Holding current value
$317,086
Previous $339 Million
4.89%
% of portfolio
0.23%
Previous 0.28%
Shares
4 transactions
Others Institutions Holding PFE
# of Institutions
3,356Shares Held
3.57BCall Options Held
86.1MPut Options Held
105M-
Vanguard Group Inc Valley Forge, PA534MShares$13.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA299MShares$7.5 Billion0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA129MShares$3.24 Billion0.22% of portfolio
-
Morgan Stanley New York, NY74.8MShares$1.88 Billion0.12% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $141B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...